Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.192 USD | -5.80% | +2.49% | -8.28% |
Mar. 05 | Top Premarket Gainers | MT |
Feb. 09 | Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.3M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -10M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.8
x | P/E ratio 2025 * |
-2.52
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.2% |
1 day | -5.80% | ||
1 week | +2.49% | ||
Current month | -9.23% | ||
1 month | -15.49% | ||
3 months | -6.64% | ||
6 months | -16.48% | ||
Current year | -8.28% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | - | 23-05-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.192 | -5.80% | 10,227 |
24-03-27 | 4.45 | +8.01% | 12,413 |
24-03-26 | 4.12 | -1.39% | 3,199 |
24-03-25 | 4.178 | -2.38% | 24,508 |
24-03-22 | 4.28 | +4.65% | 5,013 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.28% | 13.3M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |